0001179110-20-007757.txt : 20200624 0001179110-20-007757.hdr.sgml : 20200624 20200624174659 ACCESSION NUMBER: 0001179110-20-007757 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMAN STEVEN C CENTRAL INDEX KEY: 0001379970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 20986550 MAIL ADDRESS: STREET 1: 110 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-06-23 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001379970 GILMAN STEVEN C C/O MOMENTA PHARMACEUTICALS, INC 301 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 38.09 2020-06-23 4 A 0 25000 0 A 2030-06-23 Common Stock 25000 25000 D Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company. /s/ R. Mark Chamberlin as attorney in fact 2020-06-24